Hemispherx Biopharma (HEB) and USAMRIID Agree to Collaborate in Studying Alferon and Ampligen Against the Ebola Virus
Tweet Send to a Friend
Hemispherx Biopharma, Inc. (NYSE: HEB) announced that the Company and USAMRIID scientists have agreed to test Alferon®, the only multi-species ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
